Literature DB >> 7516146

Restriction enzyme analysis of American region dengue viruses.

V Vorndam1, R M Nogueira, D W Trent.   

Abstract

Restriction fragment heterogeneity of Hae III digestion products of cDNA to virion RNA was used to map the distribution of dengue virus topotypes found in the American region. By comparing the electrophoretic patterns of fragments produced, dengue virus isolates were placed in groups that agreed with those previously determined by oligonucleotide fingerprinting. Dengue-1 and dengue-4 viruses occur throughout the western hemisphere as single genetic types, with most of the isolates sharing at least 70% of their Hae III restriction enzyme fragments. Dengue-2 virus exists as two topotypes in the region with apparently non-overlapping distributions. The Puerto Rico topotype, which has been in the Caribbean for at least 40 years, is genetically diverse, while the Jamaica topotype, first isolated in 1981, is more homogeneous and has expanded its range from the original Caribbean focus to South America.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516146     DOI: 10.1007/bf01538828

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Isolation of dengue virus from a human being in Trinidad.

Authors:  C R ANDERSON; W G DOWNS; A E HILL
Journal:  Science       Date:  1956-08-03       Impact factor: 47.728

2.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

3.  Variation in dengue type 2 viruses isolated in Bangkok during 1980.

Authors:  P J Walker; E A Henchal; J Blok; P M Repik; L S Henchal; D S Burke; S J Robbins; B M Gorman
Journal:  J Gen Virol       Date:  1988-03       Impact factor: 3.891

4.  Isolation and characterization of dengue viruses serotype 1 from an epidemic in northern Queensland, Australia.

Authors:  J Blok; B H Kay; R A Hall; B M Gorman
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  Phylogenetic relationships of dengue-2 viruses.

Authors:  J A Lewis; G J Chang; R S Lanciotti; R M Kinney; L W Mayer; D W Trent
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

6.  Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants.

Authors:  S C Kliks; S Nimmanitya; A Nisalak; D S Burke
Journal:  Am J Trop Med Hyg       Date:  1988-03       Impact factor: 2.345

7.  Ross River virus mutant with a deletion in the E2 gene: properties of the virion, virus-specific macromolecule synthesis, and attenuation of virulence for mice.

Authors:  S Vrati; S G Faragher; R C Weir; L Dalgarno
Journal:  Virology       Date:  1986-06       Impact factor: 3.616

8.  Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced world-wide.

Authors:  T P Monath; R M Kinney; J J Schlesinger; M W Brandriss; P Brès
Journal:  J Gen Virol       Date:  1983-03       Impact factor: 3.891

9.  Genetic variation among dengue 2 viruses of different geographic origin.

Authors:  D W Trent; J A Grant; L Rosen; T P Monath
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

10.  Genetic differentiation of Murray Valley encephalitis virus in Australia and Papua New Guinea.

Authors:  M Lobigs; I D Marshall; R C Weir; L Dalgarno
Journal:  Aust J Exp Biol Med Sci       Date:  1986-12
View more
  3 in total

1.  Rapid subtyping of dengue virus serotypes 1 and 4 by restriction site-specific PCR.

Authors:  M P Miagostovich; F B dos Santos; C M Gutiérrez; L W Riley; E Harris
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 2.  Advances in dengue diagnosis.

Authors:  M G Guzmán; G Kourí
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

3.  Genetic diversity of the E protein of dengue type 3 virus.

Authors:  Alberto A Amarilla; Flavia T de Almeida; Daniel M Jorge; Helda L Alfonso; Luiza A de Castro-Jorge; Nadia A Nogueira; Luiz T Figueiredo; Victor H Aquino
Journal:  Virol J       Date:  2009-07-23       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.